News from NYU Langone Health
Tirzepatide bests dulaglutide for lowering cardiorenal risk
Healio Cardiology
A new analysis of the SURPASS-CVOT trial found that tirzepatide (Mounjaro) was more effective than dulaglutide (Trulicity) at reducing a composite of adverse cardiorenal events in patients with type 2 diabetes and established cardiovascular disease. Commenting on these findings, Nieca Goldberg, MD, a clinical associate professor in the department of medicine, the Leon H. Charney Division of Cardiology at NYU Langone Health, stated that the most important take-home message is that tirzepatide showed better cardiovascular and renal outcomes. Dr. Goldberg believes these results will make cardiologists look more closely at these drugs. While acknowledging that payment is a challenge, she argued that if the drugs prevent expensive hospitalizations, they could be seen as "ultimately saving money, and most importantly, saving lives."
3/28/2026
After a heart attack, beta-blockers are often a lifelong medicine. Maybe they shouldn’t be
CNN
New research suggests that lifelong beta-blocker use may not be necessary for stable patients a year after a heart attack. A study in the New England Journal of Medicine found stopping the medication did not increase the risk of death or subsequent heart events for low-risk individuals. Commenting on the findings, Joseph E. Ravenell, MD, associate professor in the Departments of Population Health and Medicine at NYU Langone Health, said that achieving similar mortality benefits without lifelong medication is a positive for both quality of life and health economics.
Also reporting was: KQTV-TV (Joseph, MO), WPSD-TV (Paducah, KY), KPXJ 21/KTBS 3 (Shreveport, LA), Yahoo Health, KVIA-TV (El Paso, TX), KTVZ-TV (Bend, OR), KEYT-TV (Santa Barbara, CA), KESQ-TV (Thousand Palms, CA), KION-TV (Salinas, CA), KRDO-TV (Colorado Springs, CO), KAPP-TV / KVEW-TV (Yakima, WA), KOAM-TV (Pittsburg, KS), WKBT-TV (La Crosse, WI), KAVU-TV (Victoria, TX), Aol
3/30/2026
It's Going to Be a Bad Tick Season. Here's How to Protect Yourself
TIME
Experts warn of a potentially severe tick season due to climate change and ecological factors expanding tick habitats and populations. The article outlines prevention strategies, including wearing protective clothing, using repellents, and performing thorough tick checks. It also details proper tick removal and symptoms of Lyme disease. Martin J. Backer, MD, clinical associate professor in the Department of Medicine at NYU Langone Health, explains the two-step testing process for Lyme disease and notes that a new vaccine candidate from Pfizer, while not perfect, offers promising protection.
3/29/2026
Battling the Bulge: The War on Obesity
Endocrine News
Endocrine News spotlights advances in obesity care, featuring insights from an Endocrine Society briefing on GLP-1 therapies where Priya Jaisinghani, MD, an endocrinologist and clinical assistant professor at NYU Langone Health, emphasized benefits beyond weight reduction, including improved insulin resistance, blood pressure, and cardiometabolic risk. Additional coverage explores links between obesity, hypertension, and dementia risk; expanding semaglutide’s clinical applications; an EHR-based measure to close the obesity diagnosis gap; and principles for person-centered obesity care. The package underscores evolving therapeutics and systems approaches to obesity management.
3/30/2026
SCIENMAG
Lisa G. Roth, MD, has been appointed director of the Division of Pediatric Hematology-Oncology at Hassenfeld Children’s Hospital at NYU Langone and Perlmutter Cancer Center. A pediatric oncologist, lymphoma survivor, and graduate of the NYU Grossman School of Medicine, she returns to NYU Langone from Weill Cornell Medicine and NewYork-Presbyterian Hospital. She also holds professorships in the Departments of Pediatrics and Pathology. In her new role, she will oversee clinical, research, and educational activities, focusing on innovative therapies for pediatric lymphomas. She succeeds Elizabeth A. Raetz, MD, who is now vice chair for clinical affairs in the Department of Pediatrics.
3/29/2026
Millions of preterm births and thousands of infant deaths linked to plastic chemical
CNN (syndicated)
A new study links two chemicals used in plastics to nearly 2 million premature births and 74,000 newborn deaths worldwide in 2018. The senior author, Leonardo Trasande, MD, the Jim G. Hendrick, M.D., Professor of Pediatrics at NYU Grossman School of Medicine and director of the Division of Environmental Pediatrics at NYU Langone Health, called phthalates a 'dangerous class of chemicals.' He stated the findings support efforts for a plastic treaty to limit such chemicals. The research, published in *eClinicalMedicine*, examined the effects of DEHP and DiNP, which are known endocrine disruptors found in many consumer products.
Also reporting was: KION-TV (Salinas, CA), KRDO-TV (Colorado Springs, CO), KOAM-TV (Pittsburg, KS), KPXJ 21/KTBS 3 (Shreveport, LA), KESQ-TV (Thousand Palms, CA), KMIZ-TV (Columbia, MO), WKBT-TV (La Crosse, WI), KAVU-TV (Victoria, TX), KAPP-TV / KVEW-TV (Yakima, WA), CNN, KEYT-TV (Santa Barbara, CA), KTVZ-TV (Bend, OR), KVIA-TV (El Paso, TX), Aol, Currently, Yahoo, KQTV-TV (Joseph, MO)
3/31/2026
As colorectal cancer rates increase among younger people, screening is vital
SmartBrief
As colorectal cancer becomes the leading cause of cancer death for Americans under 50, health experts are highlighting the importance of screening. Aasma Shaukat, MD, MPH, the Robert M. and Mary H. Glickman Professor of Medicine in the Department of Medicine at NYU Grossman School of Medicine, and director of Outcomes Research for Gastroenterology and Hepatology at NYU Langone Health, states that an unhealthy diet, a sedentary lifestyle, and obesity are contributing factors. She advises younger people to reduce red meat intake, eat more fiber, and maintain a healthy weight. Dr. Shaukat also notes that colonoscopy is the gold standard for screening, which is now recommended to begin at age 45 for average-risk individuals.
3/30/2026
Are Bad Knees an Inevitable Part of Aging? The Latest Science Says No—Here's the Truth
Women's Health
The narrative that knee pain is an inevitable part of aging is a myth, according to Abigail Campbell, MD, co-director of the Women's Sports Medicine Center at NYU Langone. She explains that knee pain is driven more by how people move and their level of physical activity rather than chronological age. While cartilage thins with age, Dr. Campbell notes that strength training is the antidote for knee pain, as it strengthens surrounding muscles to take the load off the joint. She clarifies that running does not cause or worsen arthritis.
Also reporting was: Aol, Yahoo Health, MSN India
3/30/2026
